Literature DB >> 8527116

Discontinuation of neuroleptics in community-dwelling individuals with mental retardation and mental illness.

R J Pary1.   

Abstract

Many individuals with mental retardation and mental illness who are on neuroleptics can have the dose reduced or discontinued. A recent study, however, suggests that individuals with psychosis not only may be difficult to discontinue from neuroleptics but also may require an increased neuroleptic dose. The current study is a retrospective chart review. Individuals were followed for 12 months postneuroleptic discontinuation. Individuals with a "psychotic" disorder were significantly more likely to be restarted on neuroleptics at 3 months and 12 months. A logistic regression failed to reveal any psychotic symptoms that predicted resumption on neuroleptics. An absent history of delusions, however, was significantly associated with remaining neuroleptic-free at 3 months.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527116

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  1 in total

1.  Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities.

Authors:  Kosuke Okazaki; Manabu Makinodan; Kazuhiko Yamamuro; Tomoyo Takata; Toshifumi Kishimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-14       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.